Finance

Lists
Why is 300401 down 2,93%?
Dive Deeper
300401:SHE
Zhejiang Garden Biopharmaceutical Co Ltd
CN¥13,26
-2,93%
(-0,40) 1D
15 Okt., 10:49:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300401...
Open
CN¥13,30
High
CN¥13,37
Low
CN¥13,11
Mkt. cap
7,41 mjd
Avg. vol.
24,45 m
Volume
10,68 m
Dividend
0,85%
Quarterly dividend
CN¥0,03
Ex-dividend date
27 Mei 2026
P/E ratio
28,00
52-wk high
CN¥23,44
52-wk low
CN¥10,68
EPS
CN¥0,47
Shares outstanding
544,82 m
No. of employees
1 k
Open
CN¥13,30
High
CN¥13,37
Low
CN¥13,11
Mkt. cap
7,41 mjd
Avg. vol.
24,45 m
Volume
10,68 m
Dividend
0,85%
Quarterly dividend
CN¥0,03
Ex-dividend date
27 Mei 2026
P/E ratio
28,00
52-wk high
CN¥23,44
52-wk low
CN¥10,68
EPS
CN¥0,47
Shares outstanding
544,82 m
No. of employees
1 k
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
22 minute gelede
FILE PHOTO: SK Hynix at the Nasdaq market in New York
The Globe and Mail
The Globe and Mail
·
35 minute gelede
U.S. Analyst Updates: October 14th, 2026
Investor's Business Daily
Investor's Business Daily
·
35 minute gelede
Tech Futures Fall; Anthropic Revenue Jumps, But Not Enough?
About Zhejiang Garden Biopharmaceutical Co Ltd
CEO-
Employees1,16 k
Founded18 Des. 2000
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
300,34 m
301,70 m
276,88 m
415,22 m
Cost of goods sold
136,43 m
137,15 m
141,57 m
237,45 m
Cost of revenue
136,43 m
137,15 m
141,57 m
237,45 m
Research and development expenses
14,31 m
18,22 m
23,34 m
22,43 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,41 m
49,66 m
45,59 m
45,44 m
Operating expense
62,68 m
84,79 m
68,58 m
79,74 m
Total operating expenses
199,12 m
221,94 m
210,15 m
317,19 m
Operating income
101,22 m
79,76 m
66,73 m
98,04 m
Other non operating income
1,64 m
-2,14 m
-7,93 m
8,32 m
EBT including unusual items
83,45 m
83,67 m
56,91 m
92,47 m
EBT excluding unusual items
94,32 m
69,46 m
54,19 m
88,85 m
Income tax expense
10,94 m
12,87 m
6,64 m
10,82 m
Effective tax rate
13,11%
15,38%
11,68%
11,70%
Other operating expenses
-8,31 m
17,15 m
2,77 m
8,27 m
Net income
72,51 m
70,81 m
50,27 m
81,65 m
Net profit margin
24,14%
23,47%
18,16%
19,66%
Earnings per share
-
-
-
-
Interest and investment income
2,73 m
2,73 m
2,74 m
2,60 m
Interest expense
-8,32 m
-8,97 m
-7,35 m
-7,54 m
Net interest expenses
-5,60 m
-6,24 m
-4,61 m
-4,94 m
Depreciation and amortization charges
-
-
-
-
EBITDA
140,10 m
124,28 m
111,26 m
144,42 m
Gain or loss from assets sale
159,00
2,24 m
-
-52,07 k
AI content may include mistakes. Learn more
Google-programme